Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 3 204 401 | 2 483 540 ( 77,50 %) | 0 | 77,50 % |
Unternehmenskontakt
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,83 % | 661 Mrd. | |
+27,00 % | 566 Mrd. | |
-6,76 % | 352 Mrd. | |
+20,34 % | 332 Mrd. | |
+3,00 % | 283 Mrd. | |
+13,09 % | 231 Mrd. | |
+5,46 % | 200 Mrd. | |
-9,61 % | 195 Mrd. | |
-6,26 % | 145 Mrd. |